NPI: 1770586349 · OMAHA, NE 68138 · 332B00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,156 | $220K |
| 2019 | 13,170 | $617K |
| 2020 | 10,596 | $1.13M |
| 2021 | 7,035 | $108K |
| 2022 | 6,883 | $111K |
| 2023 | 7,009 | $123K |
| 2024 | 3,628 | $47K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90378 | 575 | 452 | $1.39M | |
| J7518 | Mycophenolic acid | 6,626 | 5,878 | $364K |
| J7503 | Tacrol envarsus ex rel oral | 3,268 | 1,962 | $237K |
| J7507 | Tacrolimus imme rel oral 1mg | 10,818 | 8,212 | $125K |
| J7517 | Mycophenolate mofetil oral | 4,419 | 3,662 | $68K |
| J7520 | Sirolimus, oral | 697 | 619 | $47K |
| Q0511 | Sup fee antiem,antica,immuno | 13,089 | 11,522 | $41K |
| Q0512 | Px sup fee anti-can sub pres | 18,592 | 11,019 | $35K |
| J2315 | Naltrexone, depot form | 35 | 26 | $23K |
| J7527 | Oral everolimus | 65 | 38 | $9K |
| A4221 | Supp non-insulin inf cath/wk | 589 | 512 | $3K |
| J7515 | Cyclosporine oral 25 mg | 172 | 156 | $3K |
| J7512 | Prednisone ir or dr oral 1mg | 5,424 | 4,537 | $3K |
| J7502 | Cyclosporine oral 100 mg | 108 | 87 | $3K |